StreetInsider.com News Articles

Form 4 MiniMed Group, Inc. For: Oct 15 Filed by: Hopkins Robert (Bob)

Fri, 16 Oct 2026 17:21:00 -0400

si-local-file:///var/storage/secattach/20261016/27198734.html

Form 4 MiniMed Group, Inc. For: Oct 15 Filed by: Endicott David J.

Fri, 16 Oct 2026 17:19:00 -0400

si-local-file:///var/storage/secattach/20261016/27198713.html

Form 4 MiniMed Group, Inc. For: Oct 15 Filed by: Bricker Amy

Fri, 16 Oct 2026 17:12:00 -0400

si-local-file:///var/storage/secattach/20261016/27198658.html

Form 3 MiniMed Group, Inc. For: Oct 15 Filed by: Bricker Amy

Fri, 16 Oct 2026 16:59:00 -0400

si-local-file:///var/storage/secattach/20261016/27198530.html

Form SCHEDULE 13G/A MiniMed Group, Inc. Filed by: Medtronic plc

Fri, 16 Oct 2026 16:21:00 -0400

si-local-file:///var/storage/secattach/20261016/27198184.html

Form 4 MiniMed Group, Inc. For: Oct 15 Filed by: Medtronic plc

Fri, 16 Oct 2026 16:18:00 -0400

si-local-file:///var/storage/secattach/20261016/27198152.html

MiniMed names board following separation from Medtronic

Fri, 16 Oct 2026 08:42:23 -0400

MiniMed (Nasdaq: MMED), a diabetes technology company that completed its separation from Medtronic, announced the composition of its Board of Directors on Oct. 16, 2026.

Kevin E. Lofton, former chief executive of CommonSpirit Health, remains as chair of the board. Amy Bricker, currently Executive Vice President of Enterprise Pharmacy at Walgreens and former president of Express Scripts, joined the board effective immediately as part of a planned transition away from Medtronic-designated directors.

The full board includes MiniMed Chief Executive Que Dallara, who has led the company since March 2026 and previously served as EVP and President of Medtronic Diabetes. Other members are

MiniMed Announces Board of Directors for its Next Chapter as an Independent Company

Fri, 16 Oct 2026 08:41:00 -0400

Directors bring expertise across healthcare access, medtech, commercial operations, manufacturing and public-company governance as MiniMed begins its next chapter as an independent company focused on making every day a better day for people with diabetes.

NORTHRIDGE, Calif., Oct. 16, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the composition of its Board of Directors following the completion

MiniMed Announces Board of Directors for its Next Chapter as an Independent Company

Fri, 16 Oct 2026 08:41:00 -0400

NORTHRIDGE, Calif., Oct. 16, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the composition of its Board of Directors following the completion

Form 8-K MiniMed Group, Inc. For: Oct 15

Fri, 16 Oct 2026 08:31:00 -0400

si-local-file:///var/storage/secattach/20261016/27196002.html

MiniMed names nine-member board after Medtronic separation

Thu, 15 Oct 2026 16:10:45 -0400

MiniMed (Nasdaq: MMED), the diabetes technology company that separated from Medtronic earlier this year, announced the composition of its Board of Directors on Oct. 15, 2026, completing its governance transition as an independent public company.

Kevin E. Lofton, former chief executive of CommonSpirit Health, remains as board chair. Amy Bricker, Executive Vice President of Enterprise Pharmacy at Walgreens and former president of Express Scripts, and Timothy L. Main, former CEO and chairman of Jabil, Inc., joined the board effective immediately as part of the planned transition away from Medtronic-designated directors.

The nine-member board also includes MiniMed CEO Que Dallara, who has led

MiniMed names nine-member board after Medtronic separation

Thu, 15 Oct 2026 16:10:45 -0400

The nine-member board also includes MiniMed CEO Que Dallara, who has led

MiniMed Announces Board of Directors for its Next Chapter as an Independent Company

Thu, 15 Oct 2026 16:10:00 -0400

Directors bring expertise across healthcare access, medtech, commercial and manufacturing operations and public-company governance as MiniMed begins its next chapter as an independent company focused on making every day a better day for people with diabetes.

NORTHRIDGE, Calif., Oct. 15, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the composition of its Board of Directors following the

MiniMed Announces Board of Directors for its Next Chapter as an Independent Company

Thu, 15 Oct 2026 16:10:00 -0400

NORTHRIDGE, Calif., Oct. 15, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced the composition of its Board of Directors following the

MiniMed completes spinoff from Medtronic as independent company

Thu, 15 Oct 2026 10:06:58 -0400

MiniMed (Nasdaq: MMED) completed its separation from Medtronic plc (NYSE: MDT) on Oct. 15, 2026, becoming a fully independent publicly traded company.

As part of the transaction, Medtronic accepted 55,032,401 of its own ordinary shares in exchange for 252,813,348 shares of MiniMed common stock, leaving Medtronic with no remaining equity stake in MiniMed. The exchange offer was oversubscribed 5.4 times.

Shareholders whose Medtronic shares were accepted in the exchange will receive newly issued MiniMed shares in book-entry form. Fractional shares will be sold in the open market, with cash proceeds distributed by check.

"As an independent company, we have the freedom to make

MiniMed completes spinoff from Medtronic as independent company

Thu, 15 Oct 2026 10:06:58 -0400

MiniMed (Nasdaq: MMED) completed its separation from Medtronic plc (NYSE: MDT) on Oct. 15, 2026, becoming a fully independent publicly traded company.

"As an independent company, we have the freedom to make

MiniMed completes spinoff from Medtronic as independent company

Thu, 15 Oct 2026 10:06:58 -0400

MiniMed (Nasdaq: MMED) completed its separation from Medtronic plc (NYSE: MDT) on Oct. 15, 2026, becoming a fully independent publicly traded company.

"As an independent company, we have the freedom to make

MiniMed completes spinoff from Medtronic as independent company

Thu, 15 Oct 2026 10:06:58 -0400

MiniMed (Nasdaq: MMED) completed its separation from Medtronic plc (NYSE: MDT) on Oct. 15, 2026, becoming a fully independent publicly traded company.

"As an independent company, we have the freedom to make

MiniMed Completes Separation from Medtronic